Intuitive Surgical, Inc. (ISRG) Stock Falls Amid Market Uptick: What Investors Need to Know

15.04.25 00:00 Uhr

Werte in diesem Artikel
Aktien

422,95 EUR 3,20 EUR 0,76%

Indizes

PKT PKT

18.258,1 PKT 0,5 PKT 0,00%

16.286,5 PKT -20,7 PKT -0,13%

5.282,7 PKT 7,0 PKT 0,13%

Intuitive Surgical, Inc. (ISRG) ended the recent trading session at $490.13, demonstrating a -0.7% swing from the preceding day's closing price. The stock's performance was behind the S&P 500's daily gain of 0.79%. Elsewhere, the Dow saw an upswing of 0.78%, while the tech-heavy Nasdaq appreciated by 0.64%.Shares of the company witnessed a gain of 1.89% over the previous month, beating the performance of the Medical sector with its loss of 8.97% and the S&P 500's loss of 3.56%.The investment community will be closely monitoring the performance of Intuitive Surgical, Inc. in its forthcoming earnings report. The company is scheduled to release its earnings on April 22, 2025. The company is expected to report EPS of $1.71, up 14% from the prior-year quarter. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $2.18 billion, up 15.42% from the year-ago period.ISRG's full-year Zacks Consensus Estimates are calling for earnings of $7.97 per share and revenue of $9.56 billion. These results would represent year-over-year changes of +8.58% and +14.42%, respectively.Any recent changes to analyst estimates for Intuitive Surgical, Inc. should also be noted by investors. These recent revisions tend to reflect the evolving nature of short-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the company's business performance and profit potential.Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 0.02% lower. Intuitive Surgical, Inc. is currently a Zacks Rank #3 (Hold).Looking at its valuation, Intuitive Surgical, Inc. is holding a Forward P/E ratio of 61.91. This indicates a premium in contrast to its industry's Forward P/E of 24.12.It's also important to note that ISRG currently trades at a PEG ratio of 3.84. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. The average PEG ratio for the Medical - Instruments industry stood at 2.14 at the close of the market yesterday.The Medical - Instruments industry is part of the Medical sector. This group has a Zacks Industry Rank of 78, putting it in the top 32% of all 250+ industries.The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.You can find more information on all of these metrics, and much more, on Zacks.com.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Intuitive Surgical, Inc. (ISRG): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Intuitive Surgical und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf Intuitive Surgical

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Intuitive Surgical

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Intuitive Surgical Inc

Wer­bung

Analysen zu Intuitive Surgical Inc

DatumRatingAnalyst
19.07.2019Intuitive Surgical BuyCanaccord Adams
22.04.2019Intuitive Surgical BuyCanaccord Adams
02.04.2019Intuitive Surgical BuyDeutsche Bank AG
19.10.2018Intuitive Surgical BuyCanaccord Adams
18.04.2018Intuitive Surgical BuyCanaccord Adams
DatumRatingAnalyst
19.07.2019Intuitive Surgical BuyCanaccord Adams
22.04.2019Intuitive Surgical BuyCanaccord Adams
02.04.2019Intuitive Surgical BuyDeutsche Bank AG
19.10.2018Intuitive Surgical BuyCanaccord Adams
18.04.2018Intuitive Surgical BuyCanaccord Adams
DatumRatingAnalyst
26.01.2018Intuitive Surgical HoldCanaccord Adams
18.07.2017Intuitive Surgical Sector PerformRBC Capital Markets
30.06.2017Intuitive Surgical NeutralCantor Fitzgerald
30.05.2017Intuitive Surgical HoldCanaccord Adams
17.04.2017Intuitive Surgical Sector PerformRBC Capital Markets
DatumRatingAnalyst
23.01.2015Intuitive Surgical SellCRT Capital
22.10.2014Intuitive Surgical SellCRT Capital
09.01.2009Intuitive Surgical DowngradeBrean Murray, Carret & Co., LLC
26.08.2005Update Intuitive Surgical Inc. : UnderperformJefferies & Co

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Intuitive Surgical Inc nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen